BioSig Technologies Inc. completed a private placement of its common shares for gross proceeds of about $8.6 million.

The Los Angeles-based medical device company plans to use the proceeds for manufacturing and commercial activity.

BioSig Technologies develops a biomedical signal processing technology platform to extract information from physiologic signals.